Mendus AB: Mendus announces request of first tranche of convertible loan from Negma Group
Keep reading
Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting